Forte Biosciences, Inc. (FBRX)
Pharmaceutical Preparations
Latest Price
$76.60
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.18
P/B Ratio
64.73
Institutional Ownership
95.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 1.77M | $45.0M | 12.69% | -- | 2026-03-31 |
| FRED ALGER MANAGEMENT, LLC | 1.27M | $32.0M | 9.16% | -187.0K | 2026-03-31 |
| ORBIMED ADVISORS LLC | 1.20M | $31.0M | 8.60% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 1.19M | $30.0M | 8.54% | -237.7K | 2026-03-31 |
| Affinity Asset Advisors, LLC | 1.01M | $26.0M | 7.27% | -- | 2026-03-31 |
| MPM BIOIMPACT LLC | 1.00M | $25.0M | 7.19% | -- | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 950.0K | $24.0M | 6.83% | +616.7K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 531.7K | $13.0M | 3.82% | -- | 2026-03-31 |
| MORGAN STANLEY | 500.3K | $12.0M | 3.60% | +429.8K | 2026-03-31 |
| Cable Car Capital, LP | 400.0K | $10.0M | 2.88% | -- | 2026-03-31 |